Yuhan Corporation (KRX:000100)
119,900
+100 (0.08%)
At close: Oct 2, 2025
Yuhan Market Cap
Yuhan has a market cap or net worth of 8.97 trillion as of October 6, 2025. Its market cap has decreased by -14.81% in one year.
Market Cap
8.97T
Enterprise Value
9.02T
Revenue
2.17T
Ranking
n/a
PE Ratio
119.14
Stock Price
119,900.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 8.97T, an increase of 3,770.63%. That is a compound annual growth rate of 16.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 2, 2025 | 8,969.60B | 0.29% |
Dec 30, 2024 | 8,943.65B | 73.59% |
Dec 28, 2023 | 5,152.13B | 25.86% |
Dec 29, 2022 | 4,093.46B | -3.94% |
Dec 30, 2021 | 4,261.56B | -9.20% |
Dec 30, 2020 | 4,693.09B | 58.97% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 71.81T |
Celltrion | 38.64T |
ALTEOGEN | 25.22T |
SK Biopharmaceuticals | 8,144.58B |
Peptron | 7,006.86B |
PharmaResearch | 5,714.31B |
LigaChem Biosciences | 5,545.53B |
ABL Bio | 5,258.94B |